Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 321

Similar articles for PubMed (Select 10547289)

1.

Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.

Finley JB, Atigadda VR, Duarte F, Zhao JJ, Brouillette WJ, Air GM, Luo M.

J Mol Biol. 1999 Nov 12;293(5):1107-19.

PMID:
10547289
2.

A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase.

Lommer BS, Ali SM, Bajpai SN, Brouillette WJ, Air GM, Luo M.

Acta Crystallogr D Biol Crystallogr. 2004 Jun;60(Pt 6):1017-23. Epub 2004 May 21.

PMID:
15159560
3.

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.

Taylor NR, Cleasby A, Singh O, Skarzynski T, Wonacott AJ, Smith PW, Sollis SL, Howes PD, Cherry PC, Bethell R, Colman P, Varghese J.

J Med Chem. 1998 Mar 12;41(6):798-807.

PMID:
9526556
4.

Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction.

Singh S, Jedrzejas MJ, Air GM, Luo M, Laver WG, Brouillette WJ.

J Med Chem. 1995 Aug 18;38(17):3217-25.

PMID:
7650674
5.

Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping.

Brouillette WJ, Atigadda VR, Luo M, Air GM, Babu YS, Bantia S.

Bioorg Med Chem Lett. 1999 Jul 19;9(14):1901-6.

PMID:
10450950
6.

Structures of aromatic inhibitors of influenza virus neuraminidase.

Jedrzejas MJ, Singh S, Brouillette WJ, Laver WG, Air GM, Luo M.

Biochemistry. 1995 Mar 14;34(10):3144-51.

PMID:
7880809
7.

Guanidinobenzoic acid inhibitors of influenza virus neuraminidase.

Sudbeck EA, Jedrzejas MJ, Singh S, Brouillette WJ, Air GM, Laver WG, Babu YS, Bantia S, Chand P, Chu N, Montgomery JA, Walsh DA, Luo M.

J Mol Biol. 1997 Apr 4;267(3):584-94.

PMID:
9126840
8.

Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.

Venkatramani L, Johnson ES, Kolavi G, Air GM, Brouillette WJ, Mooers BH.

BMC Struct Biol. 2012 May 6;12:7. doi: 10.1186/1472-6807-12-7.

9.

Influenza B virus neuraminidase can synthesize its own inhibitor.

Burmeister WP, Henrissat B, Bosso C, Cusack S, Ruigrok RW.

Structure. 1993 Sep 15;1(1):19-26.

PMID:
8069621
10.

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.

Kim CU, Lew W, Williams MA, Wu H, Zhang L, Chen X, Escarpe PA, Mendel DB, Laver WG, Stevens RC.

J Med Chem. 1998 Jul 2;41(14):2451-60.

PMID:
9651151
11.
12.

Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents.

Brouillette WJ, Bajpai SN, Ali SM, Velu SE, Atigadda VR, Lommer BS, Finley JB, Luo M, Air GM.

Bioorg Med Chem. 2003 Jul 3;11(13):2739-49.

PMID:
12788348
13.

Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.

Honda T, Masuda T, Yoshida S, Arai M, Kobayashi Y, Yamashita M.

Bioorg Med Chem Lett. 2002 Aug 5;12(15):1921-4.

PMID:
12113809
14.
15.

Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.

Bossart-Whitaker P, Carson M, Babu YS, Smith CD, Laver WG, Air GM.

J Mol Biol. 1993 Aug 20;232(4):1069-83.

PMID:
8371267
16.

Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.

Zhang Q, Yang J, Liang K, Feng L, Li S, Wan J, Xu X, Yang G, Liu D, Yang S.

J Chem Inf Model. 2008 Sep;48(9):1802-12. doi: 10.1021/ci800041k. Epub 2008 Aug 16.

PMID:
18707092
17.

Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.

Atigadda VR, Brouillette WJ, Duarte F, Ali SM, Babu YS, Bantia S, Chand P, Chu N, Montgomery JA, Walsh DA, Sudbeck EA, Finley J, Luo M, Air GM, Laver GW.

J Med Chem. 1999 Jul 1;42(13):2332-43.

PMID:
10395473
18.

Combining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibition.

Dominiak PM, Volkov A, Dominiak AP, Jarzembska KN, Coppens P.

Acta Crystallogr D Biol Crystallogr. 2009 May;65(Pt 5):485-99. doi: 10.1107/S0907444909009433. Epub 2009 Apr 18.

19.
20.

Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors.

Maring CJ, Stoll VS, Zhao C, Sun M, Krueger AC, Stewart KD, Madigan DL, Kati WM, Xu Y, Carrick RJ, Montgomery DA, Kempf-Grote A, Marsh KC, Molla A, Steffy KR, Sham HL, Laver WG, Gu YG, Kempf DJ, Kohlbrenner WE.

J Med Chem. 2005 Jun 16;48(12):3980-90.

PMID:
15943472
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk